Global Longevity and Anti-Aging Drugs Market Growth 2022-2028
The report requires updating with new data and is sent in 48 hours after order is placed.
The global market for Longevity and Anti-Aging Drugs is estimated to increase from US$ million in 2021 to reach US$ million by 2028, exhibiting a CAGR of % during 2022-2028. Keeping in mind the uncertainties of COVID-19 and Russia-Ukraine War, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
The APAC Longevity and Anti-Aging Drugs market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The United States Longevity and Anti-Aging Drugs market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The Europe Longevity and Anti-Aging Drugs market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The China Longevity and Anti-Aging Drugs market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
Global key Longevity and Anti-Aging Drugs players cover Vitality Pro, MoleQlar, Hansen Supplements, Supplement Place and Maxx Herb, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
Report Coverage
This latest report provides a deep insight into the global Longevity and Anti-Aging Drugs market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, value chain analysis, etc.
This report aims to provide a comprehensive picture of the global Longevity and Anti-Aging Drugs market, with both quantitative and qualitative data, to help readers understand how the Longevity and Anti-Aging Drugs market scenario changed across the globe during the pandemic and Russia-Ukraine War.
The base year considered for analyses is 2021, while the market estimates and forecasts are given from 2022 to 2028. The market estimates are provided in terms of revenue in USD millions and volume in K Units.
Market Segmentation:
The study segments the Longevity and Anti-Aging Drugs market and forecasts the market size by Type (Calcium AKG Supplement, Nicotinamide Mononucleotide Supplement and Others), by Application (Adult Male (Under 60 Years Old), Adult Female (Under 60 Years Old) and Elderly (Above 60 Years Old),), and region (APAC, Americas, Europe, and Middle East & Africa).
Segmentation by type
Chapter 1: Scope of Longevity and Anti-Aging Drugs, Research Methodology, etc.
Chapter 2: Executive Summary, global Longevity and Anti-Aging Drugs market size (sales and revenue) and CAGR, Longevity and Anti-Aging Drugs market size by region, by type, by application, historical data from 2017 to 2022, and forecast to 2028.
Chapter 3: Longevity and Anti-Aging Drugs sales, revenue, average price, global market share, and industry ranking by company, 2017-2022
Chapter 4: Global Longevity and Anti-Aging Drugs sales and revenue by region and by country. Country specific data and market value analysis for the U.S., Canada, Europe, China, Japan, South Korea, Southeast Asia, India, Latin America and Middle East & Africa.
Chapter 5, 6, 7, 8: Americas, APAC, Europe, Middle East & Africa, sales segment by country, by type, and type.
Chapter 9: Analysis of the current market trends, market forecast, opportunities and economic trends that are affecting the future marketplace
Chapter 10: Manufacturing cost structure analysis
Chapter 11: Sales channel, distributors, and customers
Chapter 12: Global Longevity and Anti-Aging Drugs market size forecast by region, by country, by type, and application.
Chapter 13: Comprehensive company profiles of the leading players, including Vitality Pro, MoleQlar, Hansen Supplements, Supplement Place, Maxx Herb, Youth & Earth, Rejuvant LifeTabs, Renue By Science and Double Wood Supplements, etc.
Chapter 14: Research Findings and Conclusion
The global market for Longevity and Anti-Aging Drugs is estimated to increase from US$ million in 2021 to reach US$ million by 2028, exhibiting a CAGR of % during 2022-2028. Keeping in mind the uncertainties of COVID-19 and Russia-Ukraine War, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
The APAC Longevity and Anti-Aging Drugs market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The United States Longevity and Anti-Aging Drugs market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The Europe Longevity and Anti-Aging Drugs market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The China Longevity and Anti-Aging Drugs market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
Global key Longevity and Anti-Aging Drugs players cover Vitality Pro, MoleQlar, Hansen Supplements, Supplement Place and Maxx Herb, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
Report Coverage
This latest report provides a deep insight into the global Longevity and Anti-Aging Drugs market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, value chain analysis, etc.
This report aims to provide a comprehensive picture of the global Longevity and Anti-Aging Drugs market, with both quantitative and qualitative data, to help readers understand how the Longevity and Anti-Aging Drugs market scenario changed across the globe during the pandemic and Russia-Ukraine War.
The base year considered for analyses is 2021, while the market estimates and forecasts are given from 2022 to 2028. The market estimates are provided in terms of revenue in USD millions and volume in K Units.
Market Segmentation:
The study segments the Longevity and Anti-Aging Drugs market and forecasts the market size by Type (Calcium AKG Supplement, Nicotinamide Mononucleotide Supplement and Others), by Application (Adult Male (Under 60 Years Old), Adult Female (Under 60 Years Old) and Elderly (Above 60 Years Old),), and region (APAC, Americas, Europe, and Middle East & Africa).
Segmentation by type
- Calcium AKG Supplement
- Nicotinamide Mononucleotide Supplement
- Others
- Adult Male (Under 60 Years Old)
- Adult Female (Under 60 Years Old)
- Elderly (Above 60 Years Old)
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Vitality Pro
- MoleQlar
- Hansen Supplements
- Supplement Place
- Maxx Herb
- Youth & Earth
- Rejuvant LifeTabs
- Renue By Science
- Double Wood Supplements
- Quicksilver Scientific
- California Gold Nutrition
- ProHealth Longevity
- Peak Performance
- Do Not Age
- Nutriop
- AFEGA Anti-Aging-Shop
- Xi'an Angel Biotechnology Co., Ltd.
- Longevity Box
- Age Science
- Nutravita
- Aeternum
- Toniiq
- ProNutrition
- Genex Formulas
- Physicians Longevity
- AlphaFit
- Lovita Foods
- Jarrow Formulas
- Body Union
Chapter 1: Scope of Longevity and Anti-Aging Drugs, Research Methodology, etc.
Chapter 2: Executive Summary, global Longevity and Anti-Aging Drugs market size (sales and revenue) and CAGR, Longevity and Anti-Aging Drugs market size by region, by type, by application, historical data from 2017 to 2022, and forecast to 2028.
Chapter 3: Longevity and Anti-Aging Drugs sales, revenue, average price, global market share, and industry ranking by company, 2017-2022
Chapter 4: Global Longevity and Anti-Aging Drugs sales and revenue by region and by country. Country specific data and market value analysis for the U.S., Canada, Europe, China, Japan, South Korea, Southeast Asia, India, Latin America and Middle East & Africa.
Chapter 5, 6, 7, 8: Americas, APAC, Europe, Middle East & Africa, sales segment by country, by type, and type.
Chapter 9: Analysis of the current market trends, market forecast, opportunities and economic trends that are affecting the future marketplace
Chapter 10: Manufacturing cost structure analysis
Chapter 11: Sales channel, distributors, and customers
Chapter 12: Global Longevity and Anti-Aging Drugs market size forecast by region, by country, by type, and application.
Chapter 13: Comprehensive company profiles of the leading players, including Vitality Pro, MoleQlar, Hansen Supplements, Supplement Place, Maxx Herb, Youth & Earth, Rejuvant LifeTabs, Renue By Science and Double Wood Supplements, etc.
Chapter 14: Research Findings and Conclusion
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Longevity and Anti-Aging Drugs Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Longevity and Anti-Aging Drugs by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Longevity and Anti-Aging Drugs by Country/Region, 2017, 2022 & 2028
2.2 Longevity and Anti-Aging Drugs Segment by Type
2.2.1 Calcium AKG Supplement
2.2.2 Nicotinamide Mononucleotide Supplement
2.2.3 Others
2.3 Longevity and Anti-Aging Drugs Sales by Type
2.3.1 Global Longevity and Anti-Aging Drugs Sales Market Share by Type (2017-2022)
2.3.2 Global Longevity and Anti-Aging Drugs Revenue and Market Share by Type (2017-2022)
2.3.3 Global Longevity and Anti-Aging Drugs Sale Price by Type (2017-2022)
2.4 Longevity and Anti-Aging Drugs Segment by Application
2.4.1 Adult Male (Under 60 Years Old)
2.4.2 Adult Female (Under 60 Years Old)
2.4.3 Elderly (Above 60 Years Old)
2.5 Longevity and Anti-Aging Drugs Sales by Application
2.5.1 Global Longevity and Anti-Aging Drugs Sale Market Share by Application (2017-2022)
2.5.2 Global Longevity and Anti-Aging Drugs Revenue and Market Share by Application (2017-2022)
2.5.3 Global Longevity and Anti-Aging Drugs Sale Price by Application (2017-2022)
3 GLOBAL LONGEVITY AND ANTI-AGING DRUGS BY COMPANY
3.1 Global Longevity and Anti-Aging Drugs Breakdown Data by Company
3.1.1 Global Longevity and Anti-Aging Drugs Annual Sales by Company (2020-2022)
3.1.2 Global Longevity and Anti-Aging Drugs Sales Market Share by Company (2020-2022)
3.2 Global Longevity and Anti-Aging Drugs Annual Revenue by Company (2020-2022)
3.2.1 Global Longevity and Anti-Aging Drugs Revenue by Company (2020-2022)
3.2.2 Global Longevity and Anti-Aging Drugs Revenue Market Share by Company (2020-2022)
3.3 Global Longevity and Anti-Aging Drugs Sale Price by Company
3.4 Key Manufacturers Longevity and Anti-Aging Drugs Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Longevity and Anti-Aging Drugs Product Location Distribution
3.4.2 Players Longevity and Anti-Aging Drugs Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR LONGEVITY AND ANTI-AGING DRUGS BY GEOGRAPHIC REGION
4.1 World Historic Longevity and Anti-Aging Drugs Market Size by Geographic Region (2017-2022)
4.1.1 Global Longevity and Anti-Aging Drugs Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Longevity and Anti-Aging Drugs Annual Revenue by Geographic Region
4.2 World Historic Longevity and Anti-Aging Drugs Market Size by Country/Region (2017-2022)
4.2.1 Global Longevity and Anti-Aging Drugs Annual Sales by Country/Region (2017-2022)
4.2.2 Global Longevity and Anti-Aging Drugs Annual Revenue by Country/Region
4.3 Americas Longevity and Anti-Aging Drugs Sales Growth
4.4 APAC Longevity and Anti-Aging Drugs Sales Growth
4.5 Europe Longevity and Anti-Aging Drugs Sales Growth
4.6 Middle East & Africa Longevity and Anti-Aging Drugs Sales Growth
5 AMERICAS
5.1 Americas Longevity and Anti-Aging Drugs Sales by Country
5.1.1 Americas Longevity and Anti-Aging Drugs Sales by Country (2017-2022)
5.1.2 Americas Longevity and Anti-Aging Drugs Revenue by Country (2017-2022)
5.2 Americas Longevity and Anti-Aging Drugs Sales by Type
5.3 Americas Longevity and Anti-Aging Drugs Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Longevity and Anti-Aging Drugs Sales by Region
6.1.1 APAC Longevity and Anti-Aging Drugs Sales by Region (2017-2022)
6.1.2 APAC Longevity and Anti-Aging Drugs Revenue by Region (2017-2022)
6.2 APAC Longevity and Anti-Aging Drugs Sales by Type
6.3 APAC Longevity and Anti-Aging Drugs Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Longevity and Anti-Aging Drugs by Country
7.1.1 Europe Longevity and Anti-Aging Drugs Sales by Country (2017-2022)
7.1.2 Europe Longevity and Anti-Aging Drugs Revenue by Country (2017-2022)
7.2 Europe Longevity and Anti-Aging Drugs Sales by Type
7.3 Europe Longevity and Anti-Aging Drugs Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Longevity and Anti-Aging Drugs by Country
8.1.1 Middle East & Africa Longevity and Anti-Aging Drugs Sales by Country (2017-2022)
8.1.2 Middle East & Africa Longevity and Anti-Aging Drugs Revenue by Country (2017-2022)
8.2 Middle East & Africa Longevity and Anti-Aging Drugs Sales by Type
8.3 Middle East & Africa Longevity and Anti-Aging Drugs Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Longevity and Anti-Aging Drugs
10.3 Manufacturing Process Analysis of Longevity and Anti-Aging Drugs
10.4 Industry Chain Structure of Longevity and Anti-Aging Drugs
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Longevity and Anti-Aging Drugs Distributors
11.3 Longevity and Anti-Aging Drugs Customer
12 WORLD FORECAST REVIEW FOR LONGEVITY AND ANTI-AGING DRUGS BY GEOGRAPHIC REGION
12.1 Global Longevity and Anti-Aging Drugs Market Size Forecast by Region
12.1.1 Global Longevity and Anti-Aging Drugs Forecast by Region (2023-2028)
12.1.2 Global Longevity and Anti-Aging Drugs Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Longevity and Anti-Aging Drugs Forecast by Type
12.7 Global Longevity and Anti-Aging Drugs Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Vitality Pro
13.1.1 Vitality Pro Company Information
13.1.2 Vitality Pro Longevity and Anti-Aging Drugs Product Offered
13.1.3 Vitality Pro Longevity and Anti-Aging Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Vitality Pro Main Business Overview
13.1.5 Vitality Pro Latest Developments
13.2 MoleQlar
13.2.1 MoleQlar Company Information
13.2.2 MoleQlar Longevity and Anti-Aging Drugs Product Offered
13.2.3 MoleQlar Longevity and Anti-Aging Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 MoleQlar Main Business Overview
13.2.5 MoleQlar Latest Developments
13.3 Hansen Supplements
13.3.1 Hansen Supplements Company Information
13.3.2 Hansen Supplements Longevity and Anti-Aging Drugs Product Offered
13.3.3 Hansen Supplements Longevity and Anti-Aging Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Hansen Supplements Main Business Overview
13.3.5 Hansen Supplements Latest Developments
13.4 Supplement Place
13.4.1 Supplement Place Company Information
13.4.2 Supplement Place Longevity and Anti-Aging Drugs Product Offered
13.4.3 Supplement Place Longevity and Anti-Aging Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Supplement Place Main Business Overview
13.4.5 Supplement Place Latest Developments
13.5 Maxx Herb
13.5.1 Maxx Herb Company Information
13.5.2 Maxx Herb Longevity and Anti-Aging Drugs Product Offered
13.5.3 Maxx Herb Longevity and Anti-Aging Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Maxx Herb Main Business Overview
13.5.5 Maxx Herb Latest Developments
13.6 Youth & Earth
13.6.1 Youth & Earth Company Information
13.6.2 Youth & Earth Longevity and Anti-Aging Drugs Product Offered
13.6.3 Youth & Earth Longevity and Anti-Aging Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Youth & Earth Main Business Overview
13.6.5 Youth & Earth Latest Developments
13.7 Rejuvant LifeTabs
13.7.1 Rejuvant LifeTabs Company Information
13.7.2 Rejuvant LifeTabs Longevity and Anti-Aging Drugs Product Offered
13.7.3 Rejuvant LifeTabs Longevity and Anti-Aging Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Rejuvant LifeTabs Main Business Overview
13.7.5 Rejuvant LifeTabs Latest Developments
13.8 Renue By Science
13.8.1 Renue By Science Company Information
13.8.2 Renue By Science Longevity and Anti-Aging Drugs Product Offered
13.8.3 Renue By Science Longevity and Anti-Aging Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 Renue By Science Main Business Overview
13.8.5 Renue By Science Latest Developments
13.9 Double Wood Supplements
13.9.1 Double Wood Supplements Company Information
13.9.2 Double Wood Supplements Longevity and Anti-Aging Drugs Product Offered
13.9.3 Double Wood Supplements Longevity and Anti-Aging Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 Double Wood Supplements Main Business Overview
13.9.5 Double Wood Supplements Latest Developments
13.10 Quicksilver Scientific
13.10.1 Quicksilver Scientific Company Information
13.10.2 Quicksilver Scientific Longevity and Anti-Aging Drugs Product Offered
13.10.3 Quicksilver Scientific Longevity and Anti-Aging Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 Quicksilver Scientific Main Business Overview
13.10.5 Quicksilver Scientific Latest Developments
13.11 California Gold Nutrition
13.11.1 California Gold Nutrition Company Information
13.11.2 California Gold Nutrition Longevity and Anti-Aging Drugs Product Offered
13.11.3 California Gold Nutrition Longevity and Anti-Aging Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.11.4 California Gold Nutrition Main Business Overview
13.11.5 California Gold Nutrition Latest Developments
13.12 ProHealth Longevity
13.12.1 ProHealth Longevity Company Information
13.12.2 ProHealth Longevity Longevity and Anti-Aging Drugs Product Offered
13.12.3 ProHealth Longevity Longevity and Anti-Aging Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.12.4 ProHealth Longevity Main Business Overview
13.12.5 ProHealth Longevity Latest Developments
13.13 Peak Performance
13.13.1 Peak Performance Company Information
13.13.2 Peak Performance Longevity and Anti-Aging Drugs Product Offered
13.13.3 Peak Performance Longevity and Anti-Aging Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.13.4 Peak Performance Main Business Overview
13.13.5 Peak Performance Latest Developments
13.14 Do Not Age
13.14.1 Do Not Age Company Information
13.14.2 Do Not Age Longevity and Anti-Aging Drugs Product Offered
13.14.3 Do Not Age Longevity and Anti-Aging Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.14.4 Do Not Age Main Business Overview
13.14.5 Do Not Age Latest Developments
13.15 Nutriop
13.15.1 Nutriop Company Information
13.15.2 Nutriop Longevity and Anti-Aging Drugs Product Offered
13.15.3 Nutriop Longevity and Anti-Aging Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.15.4 Nutriop Main Business Overview
13.15.5 Nutriop Latest Developments
13.16 AFEGA Anti-Aging-Shop
13.16.1 AFEGA Anti-Aging-Shop Company Information
13.16.2 AFEGA Anti-Aging-Shop Longevity and Anti-Aging Drugs Product Offered
13.16.3 AFEGA Anti-Aging-Shop Longevity and Anti-Aging Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.16.4 AFEGA Anti-Aging-Shop Main Business Overview
13.16.5 AFEGA Anti-Aging-Shop Latest Developments
13.17 Xi'an Angel Biotechnology Co., Ltd.
13.17.1 Xi'an Angel Biotechnology Co., Ltd. Company Information
13.17.2 Xi'an Angel Biotechnology Co., Ltd. Longevity and Anti-Aging Drugs Product Offered
13.17.3 Xi'an Angel Biotechnology Co., Ltd. Longevity and Anti-Aging Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.17.4 Xi'an Angel Biotechnology Co., Ltd. Main Business Overview
13.17.5 Xi'an Angel Biotechnology Co., Ltd. Latest Developments
13.18 Longevity Box
13.18.1 Longevity Box Company Information
13.18.2 Longevity Box Longevity and Anti-Aging Drugs Product Offered
13.18.3 Longevity Box Longevity and Anti-Aging Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.18.4 Longevity Box Main Business Overview
13.18.5 Longevity Box Latest Developments
13.19 Age Science
13.19.1 Age Science Company Information
13.19.2 Age Science Longevity and Anti-Aging Drugs Product Offered
13.19.3 Age Science Longevity and Anti-Aging Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.19.4 Age Science Main Business Overview
13.19.5 Age Science Latest Developments
13.20 Nutravita
13.20.1 Nutravita Company Information
13.20.2 Nutravita Longevity and Anti-Aging Drugs Product Offered
13.20.3 Nutravita Longevity and Anti-Aging Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.20.4 Nutravita Main Business Overview
13.20.5 Nutravita Latest Developments
13.21 Aeternum
13.21.1 Aeternum Company Information
13.21.2 Aeternum Longevity and Anti-Aging Drugs Product Offered
13.21.3 Aeternum Longevity and Anti-Aging Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.21.4 Aeternum Main Business Overview
13.21.5 Aeternum Latest Developments
13.22 Toniiq
13.22.1 Toniiq Company Information
13.22.2 Toniiq Longevity and Anti-Aging Drugs Product Offered
13.22.3 Toniiq Longevity and Anti-Aging Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.22.4 Toniiq Main Business Overview
13.22.5 Toniiq Latest Developments
13.23 ProNutrition
13.23.1 ProNutrition Company Information
13.23.2 ProNutrition Longevity and Anti-Aging Drugs Product Offered
13.23.3 ProNutrition Longevity and Anti-Aging Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.23.4 ProNutrition Main Business Overview
13.23.5 ProNutrition Latest Developments
13.24 Genex Formulas
13.24.1 Genex Formulas Company Information
13.24.2 Genex Formulas Longevity and Anti-Aging Drugs Product Offered
13.24.3 Genex Formulas Longevity and Anti-Aging Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.24.4 Genex Formulas Main Business Overview
13.24.5 Genex Formulas Latest Developments
13.25 Physicians Longevity
13.25.1 Physicians Longevity Company Information
13.25.2 Physicians Longevity Longevity and Anti-Aging Drugs Product Offered
13.25.3 Physicians Longevity Longevity and Anti-Aging Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.25.4 Physicians Longevity Main Business Overview
13.25.5 Physicians Longevity Latest Developments
13.26 AlphaFit
13.26.1 AlphaFit Company Information
13.26.2 AlphaFit Longevity and Anti-Aging Drugs Product Offered
13.26.3 AlphaFit Longevity and Anti-Aging Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.26.4 AlphaFit Main Business Overview
13.26.5 AlphaFit Latest Developments
13.27 Lovita Foods
13.27.1 Lovita Foods Company Information
13.27.2 Lovita Foods Longevity and Anti-Aging Drugs Product Offered
13.27.3 Lovita Foods Longevity and Anti-Aging Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.27.4 Lovita Foods Main Business Overview
13.27.5 Lovita Foods Latest Developments
13.28 Jarrow Formulas
13.28.1 Jarrow Formulas Company Information
13.28.2 Jarrow Formulas Longevity and Anti-Aging Drugs Product Offered
13.28.3 Jarrow Formulas Longevity and Anti-Aging Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.28.4 Jarrow Formulas Main Business Overview
13.28.5 Jarrow Formulas Latest Developments
13.29 Body Union
13.29.1 Body Union Company Information
13.29.2 Body Union Longevity and Anti-Aging Drugs Product Offered
13.29.3 Body Union Longevity and Anti-Aging Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.29.4 Body Union Main Business Overview
13.29.5 Body Union Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Longevity and Anti-Aging Drugs Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Longevity and Anti-Aging Drugs by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Longevity and Anti-Aging Drugs by Country/Region, 2017, 2022 & 2028
2.2 Longevity and Anti-Aging Drugs Segment by Type
2.2.1 Calcium AKG Supplement
2.2.2 Nicotinamide Mononucleotide Supplement
2.2.3 Others
2.3 Longevity and Anti-Aging Drugs Sales by Type
2.3.1 Global Longevity and Anti-Aging Drugs Sales Market Share by Type (2017-2022)
2.3.2 Global Longevity and Anti-Aging Drugs Revenue and Market Share by Type (2017-2022)
2.3.3 Global Longevity and Anti-Aging Drugs Sale Price by Type (2017-2022)
2.4 Longevity and Anti-Aging Drugs Segment by Application
2.4.1 Adult Male (Under 60 Years Old)
2.4.2 Adult Female (Under 60 Years Old)
2.4.3 Elderly (Above 60 Years Old)
2.5 Longevity and Anti-Aging Drugs Sales by Application
2.5.1 Global Longevity and Anti-Aging Drugs Sale Market Share by Application (2017-2022)
2.5.2 Global Longevity and Anti-Aging Drugs Revenue and Market Share by Application (2017-2022)
2.5.3 Global Longevity and Anti-Aging Drugs Sale Price by Application (2017-2022)
3 GLOBAL LONGEVITY AND ANTI-AGING DRUGS BY COMPANY
3.1 Global Longevity and Anti-Aging Drugs Breakdown Data by Company
3.1.1 Global Longevity and Anti-Aging Drugs Annual Sales by Company (2020-2022)
3.1.2 Global Longevity and Anti-Aging Drugs Sales Market Share by Company (2020-2022)
3.2 Global Longevity and Anti-Aging Drugs Annual Revenue by Company (2020-2022)
3.2.1 Global Longevity and Anti-Aging Drugs Revenue by Company (2020-2022)
3.2.2 Global Longevity and Anti-Aging Drugs Revenue Market Share by Company (2020-2022)
3.3 Global Longevity and Anti-Aging Drugs Sale Price by Company
3.4 Key Manufacturers Longevity and Anti-Aging Drugs Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Longevity and Anti-Aging Drugs Product Location Distribution
3.4.2 Players Longevity and Anti-Aging Drugs Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR LONGEVITY AND ANTI-AGING DRUGS BY GEOGRAPHIC REGION
4.1 World Historic Longevity and Anti-Aging Drugs Market Size by Geographic Region (2017-2022)
4.1.1 Global Longevity and Anti-Aging Drugs Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Longevity and Anti-Aging Drugs Annual Revenue by Geographic Region
4.2 World Historic Longevity and Anti-Aging Drugs Market Size by Country/Region (2017-2022)
4.2.1 Global Longevity and Anti-Aging Drugs Annual Sales by Country/Region (2017-2022)
4.2.2 Global Longevity and Anti-Aging Drugs Annual Revenue by Country/Region
4.3 Americas Longevity and Anti-Aging Drugs Sales Growth
4.4 APAC Longevity and Anti-Aging Drugs Sales Growth
4.5 Europe Longevity and Anti-Aging Drugs Sales Growth
4.6 Middle East & Africa Longevity and Anti-Aging Drugs Sales Growth
5 AMERICAS
5.1 Americas Longevity and Anti-Aging Drugs Sales by Country
5.1.1 Americas Longevity and Anti-Aging Drugs Sales by Country (2017-2022)
5.1.2 Americas Longevity and Anti-Aging Drugs Revenue by Country (2017-2022)
5.2 Americas Longevity and Anti-Aging Drugs Sales by Type
5.3 Americas Longevity and Anti-Aging Drugs Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Longevity and Anti-Aging Drugs Sales by Region
6.1.1 APAC Longevity and Anti-Aging Drugs Sales by Region (2017-2022)
6.1.2 APAC Longevity and Anti-Aging Drugs Revenue by Region (2017-2022)
6.2 APAC Longevity and Anti-Aging Drugs Sales by Type
6.3 APAC Longevity and Anti-Aging Drugs Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Longevity and Anti-Aging Drugs by Country
7.1.1 Europe Longevity and Anti-Aging Drugs Sales by Country (2017-2022)
7.1.2 Europe Longevity and Anti-Aging Drugs Revenue by Country (2017-2022)
7.2 Europe Longevity and Anti-Aging Drugs Sales by Type
7.3 Europe Longevity and Anti-Aging Drugs Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Longevity and Anti-Aging Drugs by Country
8.1.1 Middle East & Africa Longevity and Anti-Aging Drugs Sales by Country (2017-2022)
8.1.2 Middle East & Africa Longevity and Anti-Aging Drugs Revenue by Country (2017-2022)
8.2 Middle East & Africa Longevity and Anti-Aging Drugs Sales by Type
8.3 Middle East & Africa Longevity and Anti-Aging Drugs Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Longevity and Anti-Aging Drugs
10.3 Manufacturing Process Analysis of Longevity and Anti-Aging Drugs
10.4 Industry Chain Structure of Longevity and Anti-Aging Drugs
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Longevity and Anti-Aging Drugs Distributors
11.3 Longevity and Anti-Aging Drugs Customer
12 WORLD FORECAST REVIEW FOR LONGEVITY AND ANTI-AGING DRUGS BY GEOGRAPHIC REGION
12.1 Global Longevity and Anti-Aging Drugs Market Size Forecast by Region
12.1.1 Global Longevity and Anti-Aging Drugs Forecast by Region (2023-2028)
12.1.2 Global Longevity and Anti-Aging Drugs Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Longevity and Anti-Aging Drugs Forecast by Type
12.7 Global Longevity and Anti-Aging Drugs Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Vitality Pro
13.1.1 Vitality Pro Company Information
13.1.2 Vitality Pro Longevity and Anti-Aging Drugs Product Offered
13.1.3 Vitality Pro Longevity and Anti-Aging Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Vitality Pro Main Business Overview
13.1.5 Vitality Pro Latest Developments
13.2 MoleQlar
13.2.1 MoleQlar Company Information
13.2.2 MoleQlar Longevity and Anti-Aging Drugs Product Offered
13.2.3 MoleQlar Longevity and Anti-Aging Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 MoleQlar Main Business Overview
13.2.5 MoleQlar Latest Developments
13.3 Hansen Supplements
13.3.1 Hansen Supplements Company Information
13.3.2 Hansen Supplements Longevity and Anti-Aging Drugs Product Offered
13.3.3 Hansen Supplements Longevity and Anti-Aging Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Hansen Supplements Main Business Overview
13.3.5 Hansen Supplements Latest Developments
13.4 Supplement Place
13.4.1 Supplement Place Company Information
13.4.2 Supplement Place Longevity and Anti-Aging Drugs Product Offered
13.4.3 Supplement Place Longevity and Anti-Aging Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Supplement Place Main Business Overview
13.4.5 Supplement Place Latest Developments
13.5 Maxx Herb
13.5.1 Maxx Herb Company Information
13.5.2 Maxx Herb Longevity and Anti-Aging Drugs Product Offered
13.5.3 Maxx Herb Longevity and Anti-Aging Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Maxx Herb Main Business Overview
13.5.5 Maxx Herb Latest Developments
13.6 Youth & Earth
13.6.1 Youth & Earth Company Information
13.6.2 Youth & Earth Longevity and Anti-Aging Drugs Product Offered
13.6.3 Youth & Earth Longevity and Anti-Aging Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Youth & Earth Main Business Overview
13.6.5 Youth & Earth Latest Developments
13.7 Rejuvant LifeTabs
13.7.1 Rejuvant LifeTabs Company Information
13.7.2 Rejuvant LifeTabs Longevity and Anti-Aging Drugs Product Offered
13.7.3 Rejuvant LifeTabs Longevity and Anti-Aging Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Rejuvant LifeTabs Main Business Overview
13.7.5 Rejuvant LifeTabs Latest Developments
13.8 Renue By Science
13.8.1 Renue By Science Company Information
13.8.2 Renue By Science Longevity and Anti-Aging Drugs Product Offered
13.8.3 Renue By Science Longevity and Anti-Aging Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 Renue By Science Main Business Overview
13.8.5 Renue By Science Latest Developments
13.9 Double Wood Supplements
13.9.1 Double Wood Supplements Company Information
13.9.2 Double Wood Supplements Longevity and Anti-Aging Drugs Product Offered
13.9.3 Double Wood Supplements Longevity and Anti-Aging Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 Double Wood Supplements Main Business Overview
13.9.5 Double Wood Supplements Latest Developments
13.10 Quicksilver Scientific
13.10.1 Quicksilver Scientific Company Information
13.10.2 Quicksilver Scientific Longevity and Anti-Aging Drugs Product Offered
13.10.3 Quicksilver Scientific Longevity and Anti-Aging Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 Quicksilver Scientific Main Business Overview
13.10.5 Quicksilver Scientific Latest Developments
13.11 California Gold Nutrition
13.11.1 California Gold Nutrition Company Information
13.11.2 California Gold Nutrition Longevity and Anti-Aging Drugs Product Offered
13.11.3 California Gold Nutrition Longevity and Anti-Aging Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.11.4 California Gold Nutrition Main Business Overview
13.11.5 California Gold Nutrition Latest Developments
13.12 ProHealth Longevity
13.12.1 ProHealth Longevity Company Information
13.12.2 ProHealth Longevity Longevity and Anti-Aging Drugs Product Offered
13.12.3 ProHealth Longevity Longevity and Anti-Aging Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.12.4 ProHealth Longevity Main Business Overview
13.12.5 ProHealth Longevity Latest Developments
13.13 Peak Performance
13.13.1 Peak Performance Company Information
13.13.2 Peak Performance Longevity and Anti-Aging Drugs Product Offered
13.13.3 Peak Performance Longevity and Anti-Aging Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.13.4 Peak Performance Main Business Overview
13.13.5 Peak Performance Latest Developments
13.14 Do Not Age
13.14.1 Do Not Age Company Information
13.14.2 Do Not Age Longevity and Anti-Aging Drugs Product Offered
13.14.3 Do Not Age Longevity and Anti-Aging Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.14.4 Do Not Age Main Business Overview
13.14.5 Do Not Age Latest Developments
13.15 Nutriop
13.15.1 Nutriop Company Information
13.15.2 Nutriop Longevity and Anti-Aging Drugs Product Offered
13.15.3 Nutriop Longevity and Anti-Aging Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.15.4 Nutriop Main Business Overview
13.15.5 Nutriop Latest Developments
13.16 AFEGA Anti-Aging-Shop
13.16.1 AFEGA Anti-Aging-Shop Company Information
13.16.2 AFEGA Anti-Aging-Shop Longevity and Anti-Aging Drugs Product Offered
13.16.3 AFEGA Anti-Aging-Shop Longevity and Anti-Aging Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.16.4 AFEGA Anti-Aging-Shop Main Business Overview
13.16.5 AFEGA Anti-Aging-Shop Latest Developments
13.17 Xi'an Angel Biotechnology Co., Ltd.
13.17.1 Xi'an Angel Biotechnology Co., Ltd. Company Information
13.17.2 Xi'an Angel Biotechnology Co., Ltd. Longevity and Anti-Aging Drugs Product Offered
13.17.3 Xi'an Angel Biotechnology Co., Ltd. Longevity and Anti-Aging Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.17.4 Xi'an Angel Biotechnology Co., Ltd. Main Business Overview
13.17.5 Xi'an Angel Biotechnology Co., Ltd. Latest Developments
13.18 Longevity Box
13.18.1 Longevity Box Company Information
13.18.2 Longevity Box Longevity and Anti-Aging Drugs Product Offered
13.18.3 Longevity Box Longevity and Anti-Aging Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.18.4 Longevity Box Main Business Overview
13.18.5 Longevity Box Latest Developments
13.19 Age Science
13.19.1 Age Science Company Information
13.19.2 Age Science Longevity and Anti-Aging Drugs Product Offered
13.19.3 Age Science Longevity and Anti-Aging Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.19.4 Age Science Main Business Overview
13.19.5 Age Science Latest Developments
13.20 Nutravita
13.20.1 Nutravita Company Information
13.20.2 Nutravita Longevity and Anti-Aging Drugs Product Offered
13.20.3 Nutravita Longevity and Anti-Aging Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.20.4 Nutravita Main Business Overview
13.20.5 Nutravita Latest Developments
13.21 Aeternum
13.21.1 Aeternum Company Information
13.21.2 Aeternum Longevity and Anti-Aging Drugs Product Offered
13.21.3 Aeternum Longevity and Anti-Aging Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.21.4 Aeternum Main Business Overview
13.21.5 Aeternum Latest Developments
13.22 Toniiq
13.22.1 Toniiq Company Information
13.22.2 Toniiq Longevity and Anti-Aging Drugs Product Offered
13.22.3 Toniiq Longevity and Anti-Aging Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.22.4 Toniiq Main Business Overview
13.22.5 Toniiq Latest Developments
13.23 ProNutrition
13.23.1 ProNutrition Company Information
13.23.2 ProNutrition Longevity and Anti-Aging Drugs Product Offered
13.23.3 ProNutrition Longevity and Anti-Aging Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.23.4 ProNutrition Main Business Overview
13.23.5 ProNutrition Latest Developments
13.24 Genex Formulas
13.24.1 Genex Formulas Company Information
13.24.2 Genex Formulas Longevity and Anti-Aging Drugs Product Offered
13.24.3 Genex Formulas Longevity and Anti-Aging Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.24.4 Genex Formulas Main Business Overview
13.24.5 Genex Formulas Latest Developments
13.25 Physicians Longevity
13.25.1 Physicians Longevity Company Information
13.25.2 Physicians Longevity Longevity and Anti-Aging Drugs Product Offered
13.25.3 Physicians Longevity Longevity and Anti-Aging Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.25.4 Physicians Longevity Main Business Overview
13.25.5 Physicians Longevity Latest Developments
13.26 AlphaFit
13.26.1 AlphaFit Company Information
13.26.2 AlphaFit Longevity and Anti-Aging Drugs Product Offered
13.26.3 AlphaFit Longevity and Anti-Aging Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.26.4 AlphaFit Main Business Overview
13.26.5 AlphaFit Latest Developments
13.27 Lovita Foods
13.27.1 Lovita Foods Company Information
13.27.2 Lovita Foods Longevity and Anti-Aging Drugs Product Offered
13.27.3 Lovita Foods Longevity and Anti-Aging Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.27.4 Lovita Foods Main Business Overview
13.27.5 Lovita Foods Latest Developments
13.28 Jarrow Formulas
13.28.1 Jarrow Formulas Company Information
13.28.2 Jarrow Formulas Longevity and Anti-Aging Drugs Product Offered
13.28.3 Jarrow Formulas Longevity and Anti-Aging Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.28.4 Jarrow Formulas Main Business Overview
13.28.5 Jarrow Formulas Latest Developments
13.29 Body Union
13.29.1 Body Union Company Information
13.29.2 Body Union Longevity and Anti-Aging Drugs Product Offered
13.29.3 Body Union Longevity and Anti-Aging Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.29.4 Body Union Main Business Overview
13.29.5 Body Union Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Longevity and Anti-Aging Drugs Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Longevity and Anti-Aging Drugs Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Calcium AKG Supplement
Table 4. Major Players of Nicotinamide Mononucleotide Supplement
Table 5. Major Players of Others
Table 6. Global Longevity and Anti-Aging Drugs Sales by Type (2017-2022) & (K Units)
Table 7. Global Longevity and Anti-Aging Drugs Sales Market Share by Type (2017-2022)
Table 8. Global Longevity and Anti-Aging Drugs Revenue by Type (2017-2022) & ($ million)
Table 9. Global Longevity and Anti-Aging Drugs Revenue Market Share by Type (2017-2022)
Table 10. Global Longevity and Anti-Aging Drugs Sale Price by Type (2017-2022) & (US$/Unit)
Table 11. Global Longevity and Anti-Aging Drugs Sales by Application (2017-2022) & (K Units)
Table 12. Global Longevity and Anti-Aging Drugs Sales Market Share by Application (2017-2022)
Table 13. Global Longevity and Anti-Aging Drugs Revenue by Application (2017-2022)
Table 14. Global Longevity and Anti-Aging Drugs Revenue Market Share by Application (2017-2022)
Table 15. Global Longevity and Anti-Aging Drugs Sale Price by Application (2017-2022) & (US$/Unit)
Table 16. Global Longevity and Anti-Aging Drugs Sales by Company (2020-2022) & (K Units)
Table 17. Global Longevity and Anti-Aging Drugs Sales Market Share by Company (2020-2022)
Table 18. Global Longevity and Anti-Aging Drugs Revenue by Company (2020-2022) ($ Millions)
Table 19. Global Longevity and Anti-Aging Drugs Revenue Market Share by Company (2020-2022)
Table 20. Global Longevity and Anti-Aging Drugs Sale Price by Company (2020-2022) & (US$/Unit)
Table 21. Key Manufacturers Longevity and Anti-Aging Drugs Producing Area Distribution and Sales Area
Table 22. Players Longevity and Anti-Aging Drugs Products Offered
Table 23. Longevity and Anti-Aging Drugs Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global Longevity and Anti-Aging Drugs Sales by Geographic Region (2017-2022) & (K Units)
Table 27. Global Longevity and Anti-Aging Drugs Sales Market Share Geographic Region (2017-2022)
Table 28. Global Longevity and Anti-Aging Drugs Revenue by Geographic Region (2017-2022) & ($ millions)
Table 29. Global Longevity and Anti-Aging Drugs Revenue Market Share by Geographic Region (2017-2022)
Table 30. Global Longevity and Anti-Aging Drugs Sales by Country/Region (2017-2022) & (K Units)
Table 31. Global Longevity and Anti-Aging Drugs Sales Market Share by Country/Region (2017-2022)
Table 32. Global Longevity and Anti-Aging Drugs Revenue by Country/Region (2017-2022) & ($ millions)
Table 33. Global Longevity and Anti-Aging Drugs Revenue Market Share by Country/Region (2017-2022)
Table 34. Americas Longevity and Anti-Aging Drugs Sales by Country (2017-2022) & (K Units)
Table 35. Americas Longevity and Anti-Aging Drugs Sales Market Share by Country (2017-2022)
Table 36. Americas Longevity and Anti-Aging Drugs Revenue by Country (2017-2022) & ($ Millions)
Table 37. Americas Longevity and Anti-Aging Drugs Revenue Market Share by Country (2017-2022)
Table 38. Americas Longevity and Anti-Aging Drugs Sales by Type (2017-2022) & (K Units)
Table 39. Americas Longevity and Anti-Aging Drugs Sales Market Share by Type (2017-2022)
Table 40. Americas Longevity and Anti-Aging Drugs Sales by Application (2017-2022) & (K Units)
Table 41. Americas Longevity and Anti-Aging Drugs Sales Market Share by Application (2017-2022)
Table 42. APAC Longevity and Anti-Aging Drugs Sales by Region (2017-2022) & (K Units)
Table 43. APAC Longevity and Anti-Aging Drugs Sales Market Share by Region (2017-2022)
Table 44. APAC Longevity and Anti-Aging Drugs Revenue by Region (2017-2022) & ($ Millions)
Table 45. APAC Longevity and Anti-Aging Drugs Revenue Market Share by Region (2017-2022)
Table 46. APAC Longevity and Anti-Aging Drugs Sales by Type (2017-2022) & (K Units)
Table 47. APAC Longevity and Anti-Aging Drugs Sales Market Share by Type (2017-2022)
Table 48. APAC Longevity and Anti-Aging Drugs Sales by Application (2017-2022) & (K Units)
Table 49. APAC Longevity and Anti-Aging Drugs Sales Market Share by Application (2017-2022)
Table 50. Europe Longevity and Anti-Aging Drugs Sales by Country (2017-2022) & (K Units)
Table 51. Europe Longevity and Anti-Aging Drugs Sales Market Share by Country (2017-2022)
Table 52. Europe Longevity and Anti-Aging Drugs Revenue by Country (2017-2022) & ($ Millions)
Table 53. Europe Longevity and Anti-Aging Drugs Revenue Market Share by Country (2017-2022)
Table 54. Europe Longevity and Anti-Aging Drugs Sales by Type (2017-2022) & (K Units)
Table 55. Europe Longevity and Anti-Aging Drugs Sales Market Share by Type (2017-2022)
Table 56. Europe Longevity and Anti-Aging Drugs Sales by Application (2017-2022) & (K Units)
Table 57. Europe Longevity and Anti-Aging Drugs Sales Market Share by Application (2017-2022)
Table 58. Middle East & Africa Longevity and Anti-Aging Drugs Sales by Country (2017-2022) & (K Units)
Table 59. Middle East & Africa Longevity and Anti-Aging Drugs Sales Market Share by Country (2017-2022)
Table 60. Middle East & Africa Longevity and Anti-Aging Drugs Revenue by Country (2017-2022) & ($ Millions)
Table 61. Middle East & Africa Longevity and Anti-Aging Drugs Revenue Market Share by Country (2017-2022)
Table 62. Middle East & Africa Longevity and Anti-Aging Drugs Sales by Type (2017-2022) & (K Units)
Table 63. Middle East & Africa Longevity and Anti-Aging Drugs Sales Market Share by Type (2017-2022)
Table 64. Middle East & Africa Longevity and Anti-Aging Drugs Sales by Application (2017-2022) & (K Units)
Table 65. Middle East & Africa Longevity and Anti-Aging Drugs Sales Market Share by Application (2017-2022)
Table 66. Key Market Drivers & Growth Opportunities of Longevity and Anti-Aging Drugs
Table 67. Key Market Challenges & Risks of Longevity and Anti-Aging Drugs
Table 68. Key Industry Trends of Longevity and Anti-Aging Drugs
Table 69. Longevity and Anti-Aging Drugs Raw Material
Table 70. Key Suppliers of Raw Materials
Table 71. Longevity and Anti-Aging Drugs Distributors List
Table 72. Longevity and Anti-Aging Drugs Customer List
Table 73. Global Longevity and Anti-Aging Drugs Sales Forecast by Region (2023-2028) & (K Units)
Table 74. Global Longevity and Anti-Aging Drugs Sales Market Forecast by Region
Table 75. Global Longevity and Anti-Aging Drugs Revenue Forecast by Region (2023-2028) & ($ millions)
Table 76. Global Longevity and Anti-Aging Drugs Revenue Market Share Forecast by Region (2023-2028)
Table 77. Americas Longevity and Anti-Aging Drugs Sales Forecast by Country (2023-2028) & (K Units)
Table 78. Americas Longevity and Anti-Aging Drugs Revenue Forecast by Country (2023-2028) & ($ millions)
Table 79. APAC Longevity and Anti-Aging Drugs Sales Forecast by Region (2023-2028) & (K Units)
Table 80. APAC Longevity and Anti-Aging Drugs Revenue Forecast by Region (2023-2028) & ($ millions)
Table 81. Europe Longevity and Anti-Aging Drugs Sales Forecast by Country (2023-2028) & (K Units)
Table 82. Europe Longevity and Anti-Aging Drugs Revenue Forecast by Country (2023-2028) & ($ millions)
Table 83. Middle East & Africa Longevity and Anti-Aging Drugs Sales Forecast by Country (2023-2028) & (K Units)
Table 84. Middle East & Africa Longevity and Anti-Aging Drugs Revenue Forecast by Country (2023-2028) & ($ millions)
Table 85. Global Longevity and Anti-Aging Drugs Sales Forecast by Type (2023-2028) & (K Units)
Table 86. Global Longevity and Anti-Aging Drugs Sales Market Share Forecast by Type (2023-2028)
Table 87. Global Longevity and Anti-Aging Drugs Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 88. Global Longevity and Anti-Aging Drugs Revenue Market Share Forecast by Type (2023-2028)
Table 89. Global Longevity and Anti-Aging Drugs Sales Forecast by Application (2023-2028) & (K Units)
Table 90. Global Longevity and Anti-Aging Drugs Sales Market Share Forecast by Application (2023-2028)
Table 91. Global Longevity and Anti-Aging Drugs Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 92. Global Longevity and Anti-Aging Drugs Revenue Market Share Forecast by Application (2023-2028)
Table 93. Vitality Pro Basic Information, Longevity and Anti-Aging Drugs Manufacturing Base, Sales Area and Its Competitors
Table 94. Vitality Pro Longevity and Anti-Aging Drugs Product Offered
Table 95. Vitality Pro Longevity and Anti-Aging Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 96. Vitality Pro Main Business
Table 97. Vitality Pro Latest Developments
Table 98. MoleQlar Basic Information, Longevity and Anti-Aging Drugs Manufacturing Base, Sales Area and Its Competitors
Table 99. MoleQlar Longevity and Anti-Aging Drugs Product Offered
Table 100. MoleQlar Longevity and Anti-Aging Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 101. MoleQlar Main Business
Table 102. MoleQlar Latest Developments
Table 103. Hansen Supplements Basic Information, Longevity and Anti-Aging Drugs Manufacturing Base, Sales Area and Its Competitors
Table 104. Hansen Supplements Longevity and Anti-Aging Drugs Product Offered
Table 105. Hansen Supplements Longevity and Anti-Aging Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 106. Hansen Supplements Main Business
Table 107. Hansen Supplements Latest Developments
Table 108. Supplement Place Basic Information, Longevity and Anti-Aging Drugs Manufacturing Base, Sales Area and Its Competitors
Table 109. Supplement Place Longevity and Anti-Aging Drugs Product Offered
Table 110. Supplement Place Longevity and Anti-Aging Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 111. Supplement Place Main Business
Table 112. Supplement Place Latest Developments
Table 113. Maxx Herb Basic Information, Longevity and Anti-Aging Drugs Manufacturing Base, Sales Area and Its Competitors
Table 114. Maxx Herb Longevity and Anti-Aging Drugs Product Offered
Table 115. Maxx Herb Longevity and Anti-Aging Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 116. Maxx Herb Main Business
Table 117. Maxx Herb Latest Developments
Table 118. Youth & Earth Basic Information, Longevity and Anti-Aging Drugs Manufacturing Base, Sales Area and Its Competitors
Table 119. Youth & Earth Longevity and Anti-Aging Drugs Product Offered
Table 120. Youth & Earth Longevity and Anti-Aging Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 121. Youth & Earth Main Business
Table 122. Youth & Earth Latest Developments
Table 123. Rejuvant LifeTabs Basic Information, Longevity and Anti-Aging Drugs Manufacturing Base, Sales Area and Its Competitors
Table 124. Rejuvant LifeTabs Longevity and Anti-Aging Drugs Product Offered
Table 125. Rejuvant LifeTabs Longevity and Anti-Aging Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 126. Rejuvant LifeTabs Main Business
Table 127. Rejuvant LifeTabs Latest Developments
Table 128. Renue By Science Basic Information, Longevity and Anti-Aging Drugs Manufacturing Base, Sales Area and Its Competitors
Table 129. Renue By Science Longevity and Anti-Aging Drugs Product Offered
Table 130. Renue By Science Longevity and Anti-Aging Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 131. Renue By Science Main Business
Table 132. Renue By Science Latest Developments
Table 133. Double Wood Supplements Basic Information, Longevity and Anti-Aging Drugs Manufacturing Base, Sales Area and Its Competitors
Table 134. Double Wood Supplements Longevity and Anti-Aging Drugs Product Offered
Table 135. Double Wood Supplements Longevity and Anti-Aging Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 136. Double Wood Supplements Main Business
Table 137. Double Wood Supplements Latest Developments
Table 138. Quicksilver Scientific Basic Information, Longevity and Anti-Aging Drugs Manufacturing Base, Sales Area and Its Competitors
Table 139. Quicksilver Scientific Longevity and Anti-Aging Drugs Product Offered
Table 140. Quicksilver Scientific Longevity and Anti-Aging Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 141. Quicksilver Scientific Main Business
Table 142. Quicksilver Scientific Latest Developments
Table 143. California Gold Nutrition Basic Information, Longevity and Anti-Aging Drugs Manufacturing Base, Sales Area and Its Competitors
Table 144. California Gold Nutrition Longevity and Anti-Aging Drugs Product Offered
Table 145. California Gold Nutrition Longevity and Anti-Aging Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 146. California Gold Nutrition Main Business
Table 147. California Gold Nutrition Latest Developments
Table 148. ProHealth Longevity Basic Information, Longevity and Anti-Aging Drugs Manufacturing Base, Sales Area and Its Competitors
Table 149. ProHealth Longevity Longevity and Anti-Aging Drugs Product Offered
Table 150. ProHealth Longevity Longevity and Anti-Aging Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 151. ProHealth Longevity Main Business
Table 152. ProHealth Longevity Latest Developments
Table 153. Peak Performance Basic Information, Longevity and Anti-Aging Drugs Manufacturing Base, Sales Area and Its Competitors
Table 154. Peak Performance Longevity and Anti-Aging Drugs Product Offered
Table 155. Peak Performance Longevity and Anti-Aging Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 156. Peak Performance Main Business
Table 157. Peak Performance Latest Developments
Table 158. Do Not Age Basic Information, Longevity and Anti-Aging Drugs Manufacturing Base, Sales Area and Its Competitors
Table 159. Do Not Age Longevity and Anti-Aging Drugs Product Offered
Table 160. Do Not Age Longevity and Anti-Aging Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 161. Do Not Age Main Business
Table 162. Do Not Age Latest Developments
Table 163. Nutriop Basic Information, Longevity and Anti-Aging Drugs Manufacturing Base, Sales Area and Its Competitors
Table 164. Nutriop Longevity and Anti-Aging Drugs Product Offered
Table 165. Nutriop Longevity and Anti-Aging Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 166. Nutriop Main Business
Table 167. Nutriop Latest Developments
Table 168. AFEGA Anti-Aging-Shop Basic Information, Longevity and Anti-Aging Drugs Manufacturing Base, Sales Area and Its Competitors
Table 169. AFEGA Anti-Aging-Shop Longevity and Anti-Aging Drugs Product Offered
Table 170. AFEGA Anti-Aging-Shop Longevity and Anti-Aging Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 171. AFEGA Anti-Aging-Shop Main Business
Table 172. AFEGA Anti-Aging-Shop Latest Developments
Table 173. Xi'an Angel Biotechnology Co., Ltd. Basic Information, Longevity and Anti-Aging Drugs Manufacturing Base, Sales Area and Its Competitors
Table 174. Xi'an Angel Biotechnology Co., Ltd. Longevity and Anti-Aging Drugs Product Offered
Table 175. Xi'an Angel Biotechnology Co., Ltd. Longevity and Anti-Aging Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 176. Xi'an Angel Biotechnology Co., Ltd. Main Business
Table 177. Xi'an Angel Biotechnology Co., Ltd. Latest Developments
Table 178. Longevity Box Basic Information, Longevity and Anti-Aging Drugs Manufacturing Base, Sales Area and Its Competitors
Table 179. Longevity Box Longevity and Anti-Aging Drugs Product Offered
Table 180. Longevity Box Longevity and Anti-Aging Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 181. Longevity Box Main Business
Table 182. Longevity Box Latest Developments
Table 183. Age Science Basic Information, Longevity and Anti-Aging Drugs Manufacturing Base, Sales Area and Its Competitors
Table 184. Age Science Longevity and Anti-Aging Drugs Product Offered
Table 185. Age Science Longevity and Anti-Aging Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 186. Age Science Main Business
Table 187. Age Science Latest Developments
Table 188. Nutravita Basic Information, Longevity and Anti-Aging Drugs Manufacturing Base, Sales Area and Its Competitors
Table 189. Nutravita Longevity and Anti-Aging Drugs Product Offered
Table 190. Nutravita Longevity and Anti-Aging Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 191. Nutravita Main Business
Table 192. Nutravita Latest Developments
Table 193. Aeternum Basic Information, Longevity and Anti-Aging Drugs Manufacturing Base, Sales Area and Its Competitors
Table 194. Aeternum Longevity and Anti-Aging Drugs Product Offered
Table 195. Aeternum Longevity and Anti-Aging Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 196. Aeternum Main Business
Table 197. Aeternum Latest Developments
Table 198. Toniiq Basic Information, Longevity and Anti-Aging Drugs Manufacturing Base, Sales Area and Its Competitors
Table 199. Toniiq Longevity and Anti-Aging Drugs Product Offered
Table 200. Toniiq Longevity and Anti-Aging Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 201. Toniiq Main Business
Table 202. Toniiq Latest Developments
Table 203. ProNutrition Basic Information, Longevity and Anti-Aging Drugs Manufacturing Base, Sales Area and Its Competitors
Table 204. ProNutrition Longevity and Anti-Aging Drugs Product Offered
Table 205. ProNutrition Longevity and Anti-Aging Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 206. ProNutrition Main Business
Table 207. ProNutrition Latest Developments
Table 208. Genex Formulas Basic Information, Longevity and Anti-Aging Drugs Manufacturing Base, Sales Area and Its Competitors
Table 209. Genex Formulas Longevity and Anti-Aging Drugs Product Offered
Table 210. Genex Formulas Longevity and Anti-Aging Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 211. Genex Formulas Main Business
Table 212. Genex Formulas Latest Developments
Table 213. Physicians Longevity Basic Information, Longevity and Anti-Aging Drugs Manufacturing Base, Sales Area and Its Competitors
Table 214. Physicians Longevity Longevity and Anti-Aging Drugs Product Offered
Table 215. Physicians Longevity Longevity and Anti-Aging Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 216. Physicians Longevity Main Business
Table 217. Physicians Longevity Latest Developments
Table 218. AlphaFit Basic Information, Longevity and Anti-Aging Drugs Manufacturing Base, Sales Area and Its Competitors
Table 219. AlphaFit Longevity and Anti-Aging Drugs Product Offered
Table 220. AlphaFit Longevity and Anti-Aging Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 221. AlphaFit Main Business
Table 222. AlphaFit Latest Developments
Table 223. Lovita Foods Basic Information, Longevity and Anti-Aging Drugs Manufacturing Base, Sales Area and Its Competitors
Table 224. Lovita Foods Longevity and Anti-Aging Drugs Product Offered
Table 225. Lovita Foods Longevity and Anti-Aging Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 226. Lovita Foods Main Business
Table 227. Lovita Foods Latest Developments
Table 228. Jarrow Formulas Basic Information, Longevity and Anti-Aging Drugs Manufacturing Base, Sales Area and Its Competitors
Table 229. Jarrow Formulas Longevity and Anti-Aging Drugs Product Offered
Table 230. Jarrow Formulas Longevity and Anti-Aging Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 231. Jarrow Formulas Main Business
Table 232. Jarrow Formulas Latest Developments
Table 233. Body Union Basic Information, Longevity and Anti-Aging Drugs Manufacturing Base, Sales Area and Its Competitors
Table 234. Body Union Longevity and Anti-Aging Drugs Product Offered
Table 235. Body Union Longevity and Anti-Aging Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 236. Body Union Main Business
Table 237. Body Union Latest Developments
Table 1. Longevity and Anti-Aging Drugs Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Longevity and Anti-Aging Drugs Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Calcium AKG Supplement
Table 4. Major Players of Nicotinamide Mononucleotide Supplement
Table 5. Major Players of Others
Table 6. Global Longevity and Anti-Aging Drugs Sales by Type (2017-2022) & (K Units)
Table 7. Global Longevity and Anti-Aging Drugs Sales Market Share by Type (2017-2022)
Table 8. Global Longevity and Anti-Aging Drugs Revenue by Type (2017-2022) & ($ million)
Table 9. Global Longevity and Anti-Aging Drugs Revenue Market Share by Type (2017-2022)
Table 10. Global Longevity and Anti-Aging Drugs Sale Price by Type (2017-2022) & (US$/Unit)
Table 11. Global Longevity and Anti-Aging Drugs Sales by Application (2017-2022) & (K Units)
Table 12. Global Longevity and Anti-Aging Drugs Sales Market Share by Application (2017-2022)
Table 13. Global Longevity and Anti-Aging Drugs Revenue by Application (2017-2022)
Table 14. Global Longevity and Anti-Aging Drugs Revenue Market Share by Application (2017-2022)
Table 15. Global Longevity and Anti-Aging Drugs Sale Price by Application (2017-2022) & (US$/Unit)
Table 16. Global Longevity and Anti-Aging Drugs Sales by Company (2020-2022) & (K Units)
Table 17. Global Longevity and Anti-Aging Drugs Sales Market Share by Company (2020-2022)
Table 18. Global Longevity and Anti-Aging Drugs Revenue by Company (2020-2022) ($ Millions)
Table 19. Global Longevity and Anti-Aging Drugs Revenue Market Share by Company (2020-2022)
Table 20. Global Longevity and Anti-Aging Drugs Sale Price by Company (2020-2022) & (US$/Unit)
Table 21. Key Manufacturers Longevity and Anti-Aging Drugs Producing Area Distribution and Sales Area
Table 22. Players Longevity and Anti-Aging Drugs Products Offered
Table 23. Longevity and Anti-Aging Drugs Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global Longevity and Anti-Aging Drugs Sales by Geographic Region (2017-2022) & (K Units)
Table 27. Global Longevity and Anti-Aging Drugs Sales Market Share Geographic Region (2017-2022)
Table 28. Global Longevity and Anti-Aging Drugs Revenue by Geographic Region (2017-2022) & ($ millions)
Table 29. Global Longevity and Anti-Aging Drugs Revenue Market Share by Geographic Region (2017-2022)
Table 30. Global Longevity and Anti-Aging Drugs Sales by Country/Region (2017-2022) & (K Units)
Table 31. Global Longevity and Anti-Aging Drugs Sales Market Share by Country/Region (2017-2022)
Table 32. Global Longevity and Anti-Aging Drugs Revenue by Country/Region (2017-2022) & ($ millions)
Table 33. Global Longevity and Anti-Aging Drugs Revenue Market Share by Country/Region (2017-2022)
Table 34. Americas Longevity and Anti-Aging Drugs Sales by Country (2017-2022) & (K Units)
Table 35. Americas Longevity and Anti-Aging Drugs Sales Market Share by Country (2017-2022)
Table 36. Americas Longevity and Anti-Aging Drugs Revenue by Country (2017-2022) & ($ Millions)
Table 37. Americas Longevity and Anti-Aging Drugs Revenue Market Share by Country (2017-2022)
Table 38. Americas Longevity and Anti-Aging Drugs Sales by Type (2017-2022) & (K Units)
Table 39. Americas Longevity and Anti-Aging Drugs Sales Market Share by Type (2017-2022)
Table 40. Americas Longevity and Anti-Aging Drugs Sales by Application (2017-2022) & (K Units)
Table 41. Americas Longevity and Anti-Aging Drugs Sales Market Share by Application (2017-2022)
Table 42. APAC Longevity and Anti-Aging Drugs Sales by Region (2017-2022) & (K Units)
Table 43. APAC Longevity and Anti-Aging Drugs Sales Market Share by Region (2017-2022)
Table 44. APAC Longevity and Anti-Aging Drugs Revenue by Region (2017-2022) & ($ Millions)
Table 45. APAC Longevity and Anti-Aging Drugs Revenue Market Share by Region (2017-2022)
Table 46. APAC Longevity and Anti-Aging Drugs Sales by Type (2017-2022) & (K Units)
Table 47. APAC Longevity and Anti-Aging Drugs Sales Market Share by Type (2017-2022)
Table 48. APAC Longevity and Anti-Aging Drugs Sales by Application (2017-2022) & (K Units)
Table 49. APAC Longevity and Anti-Aging Drugs Sales Market Share by Application (2017-2022)
Table 50. Europe Longevity and Anti-Aging Drugs Sales by Country (2017-2022) & (K Units)
Table 51. Europe Longevity and Anti-Aging Drugs Sales Market Share by Country (2017-2022)
Table 52. Europe Longevity and Anti-Aging Drugs Revenue by Country (2017-2022) & ($ Millions)
Table 53. Europe Longevity and Anti-Aging Drugs Revenue Market Share by Country (2017-2022)
Table 54. Europe Longevity and Anti-Aging Drugs Sales by Type (2017-2022) & (K Units)
Table 55. Europe Longevity and Anti-Aging Drugs Sales Market Share by Type (2017-2022)
Table 56. Europe Longevity and Anti-Aging Drugs Sales by Application (2017-2022) & (K Units)
Table 57. Europe Longevity and Anti-Aging Drugs Sales Market Share by Application (2017-2022)
Table 58. Middle East & Africa Longevity and Anti-Aging Drugs Sales by Country (2017-2022) & (K Units)
Table 59. Middle East & Africa Longevity and Anti-Aging Drugs Sales Market Share by Country (2017-2022)
Table 60. Middle East & Africa Longevity and Anti-Aging Drugs Revenue by Country (2017-2022) & ($ Millions)
Table 61. Middle East & Africa Longevity and Anti-Aging Drugs Revenue Market Share by Country (2017-2022)
Table 62. Middle East & Africa Longevity and Anti-Aging Drugs Sales by Type (2017-2022) & (K Units)
Table 63. Middle East & Africa Longevity and Anti-Aging Drugs Sales Market Share by Type (2017-2022)
Table 64. Middle East & Africa Longevity and Anti-Aging Drugs Sales by Application (2017-2022) & (K Units)
Table 65. Middle East & Africa Longevity and Anti-Aging Drugs Sales Market Share by Application (2017-2022)
Table 66. Key Market Drivers & Growth Opportunities of Longevity and Anti-Aging Drugs
Table 67. Key Market Challenges & Risks of Longevity and Anti-Aging Drugs
Table 68. Key Industry Trends of Longevity and Anti-Aging Drugs
Table 69. Longevity and Anti-Aging Drugs Raw Material
Table 70. Key Suppliers of Raw Materials
Table 71. Longevity and Anti-Aging Drugs Distributors List
Table 72. Longevity and Anti-Aging Drugs Customer List
Table 73. Global Longevity and Anti-Aging Drugs Sales Forecast by Region (2023-2028) & (K Units)
Table 74. Global Longevity and Anti-Aging Drugs Sales Market Forecast by Region
Table 75. Global Longevity and Anti-Aging Drugs Revenue Forecast by Region (2023-2028) & ($ millions)
Table 76. Global Longevity and Anti-Aging Drugs Revenue Market Share Forecast by Region (2023-2028)
Table 77. Americas Longevity and Anti-Aging Drugs Sales Forecast by Country (2023-2028) & (K Units)
Table 78. Americas Longevity and Anti-Aging Drugs Revenue Forecast by Country (2023-2028) & ($ millions)
Table 79. APAC Longevity and Anti-Aging Drugs Sales Forecast by Region (2023-2028) & (K Units)
Table 80. APAC Longevity and Anti-Aging Drugs Revenue Forecast by Region (2023-2028) & ($ millions)
Table 81. Europe Longevity and Anti-Aging Drugs Sales Forecast by Country (2023-2028) & (K Units)
Table 82. Europe Longevity and Anti-Aging Drugs Revenue Forecast by Country (2023-2028) & ($ millions)
Table 83. Middle East & Africa Longevity and Anti-Aging Drugs Sales Forecast by Country (2023-2028) & (K Units)
Table 84. Middle East & Africa Longevity and Anti-Aging Drugs Revenue Forecast by Country (2023-2028) & ($ millions)
Table 85. Global Longevity and Anti-Aging Drugs Sales Forecast by Type (2023-2028) & (K Units)
Table 86. Global Longevity and Anti-Aging Drugs Sales Market Share Forecast by Type (2023-2028)
Table 87. Global Longevity and Anti-Aging Drugs Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 88. Global Longevity and Anti-Aging Drugs Revenue Market Share Forecast by Type (2023-2028)
Table 89. Global Longevity and Anti-Aging Drugs Sales Forecast by Application (2023-2028) & (K Units)
Table 90. Global Longevity and Anti-Aging Drugs Sales Market Share Forecast by Application (2023-2028)
Table 91. Global Longevity and Anti-Aging Drugs Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 92. Global Longevity and Anti-Aging Drugs Revenue Market Share Forecast by Application (2023-2028)
Table 93. Vitality Pro Basic Information, Longevity and Anti-Aging Drugs Manufacturing Base, Sales Area and Its Competitors
Table 94. Vitality Pro Longevity and Anti-Aging Drugs Product Offered
Table 95. Vitality Pro Longevity and Anti-Aging Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 96. Vitality Pro Main Business
Table 97. Vitality Pro Latest Developments
Table 98. MoleQlar Basic Information, Longevity and Anti-Aging Drugs Manufacturing Base, Sales Area and Its Competitors
Table 99. MoleQlar Longevity and Anti-Aging Drugs Product Offered
Table 100. MoleQlar Longevity and Anti-Aging Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 101. MoleQlar Main Business
Table 102. MoleQlar Latest Developments
Table 103. Hansen Supplements Basic Information, Longevity and Anti-Aging Drugs Manufacturing Base, Sales Area and Its Competitors
Table 104. Hansen Supplements Longevity and Anti-Aging Drugs Product Offered
Table 105. Hansen Supplements Longevity and Anti-Aging Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 106. Hansen Supplements Main Business
Table 107. Hansen Supplements Latest Developments
Table 108. Supplement Place Basic Information, Longevity and Anti-Aging Drugs Manufacturing Base, Sales Area and Its Competitors
Table 109. Supplement Place Longevity and Anti-Aging Drugs Product Offered
Table 110. Supplement Place Longevity and Anti-Aging Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 111. Supplement Place Main Business
Table 112. Supplement Place Latest Developments
Table 113. Maxx Herb Basic Information, Longevity and Anti-Aging Drugs Manufacturing Base, Sales Area and Its Competitors
Table 114. Maxx Herb Longevity and Anti-Aging Drugs Product Offered
Table 115. Maxx Herb Longevity and Anti-Aging Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 116. Maxx Herb Main Business
Table 117. Maxx Herb Latest Developments
Table 118. Youth & Earth Basic Information, Longevity and Anti-Aging Drugs Manufacturing Base, Sales Area and Its Competitors
Table 119. Youth & Earth Longevity and Anti-Aging Drugs Product Offered
Table 120. Youth & Earth Longevity and Anti-Aging Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 121. Youth & Earth Main Business
Table 122. Youth & Earth Latest Developments
Table 123. Rejuvant LifeTabs Basic Information, Longevity and Anti-Aging Drugs Manufacturing Base, Sales Area and Its Competitors
Table 124. Rejuvant LifeTabs Longevity and Anti-Aging Drugs Product Offered
Table 125. Rejuvant LifeTabs Longevity and Anti-Aging Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 126. Rejuvant LifeTabs Main Business
Table 127. Rejuvant LifeTabs Latest Developments
Table 128. Renue By Science Basic Information, Longevity and Anti-Aging Drugs Manufacturing Base, Sales Area and Its Competitors
Table 129. Renue By Science Longevity and Anti-Aging Drugs Product Offered
Table 130. Renue By Science Longevity and Anti-Aging Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 131. Renue By Science Main Business
Table 132. Renue By Science Latest Developments
Table 133. Double Wood Supplements Basic Information, Longevity and Anti-Aging Drugs Manufacturing Base, Sales Area and Its Competitors
Table 134. Double Wood Supplements Longevity and Anti-Aging Drugs Product Offered
Table 135. Double Wood Supplements Longevity and Anti-Aging Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 136. Double Wood Supplements Main Business
Table 137. Double Wood Supplements Latest Developments
Table 138. Quicksilver Scientific Basic Information, Longevity and Anti-Aging Drugs Manufacturing Base, Sales Area and Its Competitors
Table 139. Quicksilver Scientific Longevity and Anti-Aging Drugs Product Offered
Table 140. Quicksilver Scientific Longevity and Anti-Aging Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 141. Quicksilver Scientific Main Business
Table 142. Quicksilver Scientific Latest Developments
Table 143. California Gold Nutrition Basic Information, Longevity and Anti-Aging Drugs Manufacturing Base, Sales Area and Its Competitors
Table 144. California Gold Nutrition Longevity and Anti-Aging Drugs Product Offered
Table 145. California Gold Nutrition Longevity and Anti-Aging Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 146. California Gold Nutrition Main Business
Table 147. California Gold Nutrition Latest Developments
Table 148. ProHealth Longevity Basic Information, Longevity and Anti-Aging Drugs Manufacturing Base, Sales Area and Its Competitors
Table 149. ProHealth Longevity Longevity and Anti-Aging Drugs Product Offered
Table 150. ProHealth Longevity Longevity and Anti-Aging Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 151. ProHealth Longevity Main Business
Table 152. ProHealth Longevity Latest Developments
Table 153. Peak Performance Basic Information, Longevity and Anti-Aging Drugs Manufacturing Base, Sales Area and Its Competitors
Table 154. Peak Performance Longevity and Anti-Aging Drugs Product Offered
Table 155. Peak Performance Longevity and Anti-Aging Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 156. Peak Performance Main Business
Table 157. Peak Performance Latest Developments
Table 158. Do Not Age Basic Information, Longevity and Anti-Aging Drugs Manufacturing Base, Sales Area and Its Competitors
Table 159. Do Not Age Longevity and Anti-Aging Drugs Product Offered
Table 160. Do Not Age Longevity and Anti-Aging Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 161. Do Not Age Main Business
Table 162. Do Not Age Latest Developments
Table 163. Nutriop Basic Information, Longevity and Anti-Aging Drugs Manufacturing Base, Sales Area and Its Competitors
Table 164. Nutriop Longevity and Anti-Aging Drugs Product Offered
Table 165. Nutriop Longevity and Anti-Aging Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 166. Nutriop Main Business
Table 167. Nutriop Latest Developments
Table 168. AFEGA Anti-Aging-Shop Basic Information, Longevity and Anti-Aging Drugs Manufacturing Base, Sales Area and Its Competitors
Table 169. AFEGA Anti-Aging-Shop Longevity and Anti-Aging Drugs Product Offered
Table 170. AFEGA Anti-Aging-Shop Longevity and Anti-Aging Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 171. AFEGA Anti-Aging-Shop Main Business
Table 172. AFEGA Anti-Aging-Shop Latest Developments
Table 173. Xi'an Angel Biotechnology Co., Ltd. Basic Information, Longevity and Anti-Aging Drugs Manufacturing Base, Sales Area and Its Competitors
Table 174. Xi'an Angel Biotechnology Co., Ltd. Longevity and Anti-Aging Drugs Product Offered
Table 175. Xi'an Angel Biotechnology Co., Ltd. Longevity and Anti-Aging Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 176. Xi'an Angel Biotechnology Co., Ltd. Main Business
Table 177. Xi'an Angel Biotechnology Co., Ltd. Latest Developments
Table 178. Longevity Box Basic Information, Longevity and Anti-Aging Drugs Manufacturing Base, Sales Area and Its Competitors
Table 179. Longevity Box Longevity and Anti-Aging Drugs Product Offered
Table 180. Longevity Box Longevity and Anti-Aging Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 181. Longevity Box Main Business
Table 182. Longevity Box Latest Developments
Table 183. Age Science Basic Information, Longevity and Anti-Aging Drugs Manufacturing Base, Sales Area and Its Competitors
Table 184. Age Science Longevity and Anti-Aging Drugs Product Offered
Table 185. Age Science Longevity and Anti-Aging Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 186. Age Science Main Business
Table 187. Age Science Latest Developments
Table 188. Nutravita Basic Information, Longevity and Anti-Aging Drugs Manufacturing Base, Sales Area and Its Competitors
Table 189. Nutravita Longevity and Anti-Aging Drugs Product Offered
Table 190. Nutravita Longevity and Anti-Aging Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 191. Nutravita Main Business
Table 192. Nutravita Latest Developments
Table 193. Aeternum Basic Information, Longevity and Anti-Aging Drugs Manufacturing Base, Sales Area and Its Competitors
Table 194. Aeternum Longevity and Anti-Aging Drugs Product Offered
Table 195. Aeternum Longevity and Anti-Aging Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 196. Aeternum Main Business
Table 197. Aeternum Latest Developments
Table 198. Toniiq Basic Information, Longevity and Anti-Aging Drugs Manufacturing Base, Sales Area and Its Competitors
Table 199. Toniiq Longevity and Anti-Aging Drugs Product Offered
Table 200. Toniiq Longevity and Anti-Aging Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 201. Toniiq Main Business
Table 202. Toniiq Latest Developments
Table 203. ProNutrition Basic Information, Longevity and Anti-Aging Drugs Manufacturing Base, Sales Area and Its Competitors
Table 204. ProNutrition Longevity and Anti-Aging Drugs Product Offered
Table 205. ProNutrition Longevity and Anti-Aging Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 206. ProNutrition Main Business
Table 207. ProNutrition Latest Developments
Table 208. Genex Formulas Basic Information, Longevity and Anti-Aging Drugs Manufacturing Base, Sales Area and Its Competitors
Table 209. Genex Formulas Longevity and Anti-Aging Drugs Product Offered
Table 210. Genex Formulas Longevity and Anti-Aging Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 211. Genex Formulas Main Business
Table 212. Genex Formulas Latest Developments
Table 213. Physicians Longevity Basic Information, Longevity and Anti-Aging Drugs Manufacturing Base, Sales Area and Its Competitors
Table 214. Physicians Longevity Longevity and Anti-Aging Drugs Product Offered
Table 215. Physicians Longevity Longevity and Anti-Aging Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 216. Physicians Longevity Main Business
Table 217. Physicians Longevity Latest Developments
Table 218. AlphaFit Basic Information, Longevity and Anti-Aging Drugs Manufacturing Base, Sales Area and Its Competitors
Table 219. AlphaFit Longevity and Anti-Aging Drugs Product Offered
Table 220. AlphaFit Longevity and Anti-Aging Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 221. AlphaFit Main Business
Table 222. AlphaFit Latest Developments
Table 223. Lovita Foods Basic Information, Longevity and Anti-Aging Drugs Manufacturing Base, Sales Area and Its Competitors
Table 224. Lovita Foods Longevity and Anti-Aging Drugs Product Offered
Table 225. Lovita Foods Longevity and Anti-Aging Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 226. Lovita Foods Main Business
Table 227. Lovita Foods Latest Developments
Table 228. Jarrow Formulas Basic Information, Longevity and Anti-Aging Drugs Manufacturing Base, Sales Area and Its Competitors
Table 229. Jarrow Formulas Longevity and Anti-Aging Drugs Product Offered
Table 230. Jarrow Formulas Longevity and Anti-Aging Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 231. Jarrow Formulas Main Business
Table 232. Jarrow Formulas Latest Developments
Table 233. Body Union Basic Information, Longevity and Anti-Aging Drugs Manufacturing Base, Sales Area and Its Competitors
Table 234. Body Union Longevity and Anti-Aging Drugs Product Offered
Table 235. Body Union Longevity and Anti-Aging Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 236. Body Union Main Business
Table 237. Body Union Latest Developments
LIST OF FIGURES
Figure 1. Picture of Longevity and Anti-Aging Drugs
Figure 2. Longevity and Anti-Aging Drugs Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Longevity and Anti-Aging Drugs Sales Growth Rate 2017-2028 (K Units)
Figure 7. Global Longevity and Anti-Aging Drugs Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Longevity and Anti-Aging Drugs Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Calcium AKG Supplement
Figure 10. Product Picture of Nicotinamide Mononucleotide Supplement
Figure 11. Product Picture of Others
Figure 12. Global Longevity and Anti-Aging Drugs Sales Market Share by Type in 2021
Figure 13. Global Longevity and Anti-Aging Drugs Revenue Market Share by Type (2017-2022)
Figure 14. Longevity and Anti-Aging Drugs Consumed in Adult Male (Under 60 Years Old)
Figure 15. Global Longevity and Anti-Aging Drugs Market: Adult Male (Under 60 Years Old) (2017-2022) & (K Units)
Figure 16. Longevity and Anti-Aging Drugs Consumed in Adult Female (Under 60 Years Old)
Figure 17. Global Longevity and Anti-Aging Drugs Market: Adult Female (Under 60 Years Old) (2017-2022) & (K Units)
Figure 18. Longevity and Anti-Aging Drugs Consumed in Elderly (Above 60 Years Old)
Figure 19. Global Longevity and Anti-Aging Drugs Market: Elderly (Above 60 Years Old) (2017-2022) & (K Units)
Figure 20. Global Longevity and Anti-Aging Drugs Sales Market Share by Application (2017-2022)
Figure 21. Global Longevity and Anti-Aging Drugs Revenue Market Share by Application in 2021
Figure 22. Longevity and Anti-Aging Drugs Revenue Market by Company in 2021 ($ Million)
Figure 23. Global Longevity and Anti-Aging Drugs Revenue Market Share by Company in 2021
Figure 24. Global Longevity and Anti-Aging Drugs Sales Market Share by Geographic Region (2017-2022)
Figure 25. Global Longevity and Anti-Aging Drugs Revenue Market Share by Geographic Region in 2021
Figure 26. Global Longevity and Anti-Aging Drugs Sales Market Share by Region (2017-2022)
Figure 27. Global Longevity and Anti-Aging Drugs Revenue Market Share by Country/Region in 2021
Figure 28. Americas Longevity and Anti-Aging Drugs Sales 2017-2022 (K Units)
Figure 29. Americas Longevity and Anti-Aging Drugs Revenue 2017-2022 ($ Millions)
Figure 30. APAC Longevity and Anti-Aging Drugs Sales 2017-2022 (K Units)
Figure 31. APAC Longevity and Anti-Aging Drugs Revenue 2017-2022 ($ Millions)
Figure 32. Europe Longevity and Anti-Aging Drugs Sales 2017-2022 (K Units)
Figure 33. Europe Longevity and Anti-Aging Drugs Revenue 2017-2022 ($ Millions)
Figure 34. Middle East & Africa Longevity and Anti-Aging Drugs Sales 2017-2022 (K Units)
Figure 35. Middle East & Africa Longevity and Anti-Aging Drugs Revenue 2017-2022 ($ Millions)
Figure 36. Americas Longevity and Anti-Aging Drugs Sales Market Share by Country in 2021
Figure 37. Americas Longevity and Anti-Aging Drugs Revenue Market Share by Country in 2021
Figure 38. United States Longevity and Anti-Aging Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 39. Canada Longevity and Anti-Aging Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 40. Mexico Longevity and Anti-Aging Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 41. Brazil Longevity and Anti-Aging Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 42. APAC Longevity and Anti-Aging Drugs Sales Market Share by Region in 2021
Figure 43. APAC Longevity and Anti-Aging Drugs Revenue Market Share by Regions in 2021
Figure 44. China Longevity and Anti-Aging Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 45. Japan Longevity and Anti-Aging Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 46. South Korea Longevity and Anti-Aging Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 47. Southeast Asia Longevity and Anti-Aging Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 48. India Longevity and Anti-Aging Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 49. Australia Longevity and Anti-Aging Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 50. Europe Longevity and Anti-Aging Drugs Sales Market Share by Country in 2021
Figure 51. Europe Longevity and Anti-Aging Drugs Revenue Market Share by Country in 2021
Figure 52. Germany Longevity and Anti-Aging Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 53. France Longevity and Anti-Aging Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 54. UK Longevity and Anti-Aging Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 55. Italy Longevity and Anti-Aging Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 56. Russia Longevity and Anti-Aging Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 57. Middle East & Africa Longevity and Anti-Aging Drugs Sales Market Share by Country in 2021
Figure 58. Middle East & Africa Longevity and Anti-Aging Drugs Revenue Market Share by Country in 2021
Figure 59. Egypt Longevity and Anti-Aging Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 60. South Africa Longevity and Anti-Aging Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 61. Israel Longevity and Anti-Aging Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 62. Turkey Longevity and Anti-Aging Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 63. GCC Country Longevity and Anti-Aging Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 64. Manufacturing Cost Structure Analysis of Longevity and Anti-Aging Drugs in 2021
Figure 65. Manufacturing Process Analysis of Longevity and Anti-Aging Drugs
Figure 66. Industry Chain Structure of Longevity and Anti-Aging Drugs
Figure 67. Channels of Distribution
Figure 68. Distributors Profiles
Figure 1. Picture of Longevity and Anti-Aging Drugs
Figure 2. Longevity and Anti-Aging Drugs Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Longevity and Anti-Aging Drugs Sales Growth Rate 2017-2028 (K Units)
Figure 7. Global Longevity and Anti-Aging Drugs Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Longevity and Anti-Aging Drugs Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Calcium AKG Supplement
Figure 10. Product Picture of Nicotinamide Mononucleotide Supplement
Figure 11. Product Picture of Others
Figure 12. Global Longevity and Anti-Aging Drugs Sales Market Share by Type in 2021
Figure 13. Global Longevity and Anti-Aging Drugs Revenue Market Share by Type (2017-2022)
Figure 14. Longevity and Anti-Aging Drugs Consumed in Adult Male (Under 60 Years Old)
Figure 15. Global Longevity and Anti-Aging Drugs Market: Adult Male (Under 60 Years Old) (2017-2022) & (K Units)
Figure 16. Longevity and Anti-Aging Drugs Consumed in Adult Female (Under 60 Years Old)
Figure 17. Global Longevity and Anti-Aging Drugs Market: Adult Female (Under 60 Years Old) (2017-2022) & (K Units)
Figure 18. Longevity and Anti-Aging Drugs Consumed in Elderly (Above 60 Years Old)
Figure 19. Global Longevity and Anti-Aging Drugs Market: Elderly (Above 60 Years Old) (2017-2022) & (K Units)
Figure 20. Global Longevity and Anti-Aging Drugs Sales Market Share by Application (2017-2022)
Figure 21. Global Longevity and Anti-Aging Drugs Revenue Market Share by Application in 2021
Figure 22. Longevity and Anti-Aging Drugs Revenue Market by Company in 2021 ($ Million)
Figure 23. Global Longevity and Anti-Aging Drugs Revenue Market Share by Company in 2021
Figure 24. Global Longevity and Anti-Aging Drugs Sales Market Share by Geographic Region (2017-2022)
Figure 25. Global Longevity and Anti-Aging Drugs Revenue Market Share by Geographic Region in 2021
Figure 26. Global Longevity and Anti-Aging Drugs Sales Market Share by Region (2017-2022)
Figure 27. Global Longevity and Anti-Aging Drugs Revenue Market Share by Country/Region in 2021
Figure 28. Americas Longevity and Anti-Aging Drugs Sales 2017-2022 (K Units)
Figure 29. Americas Longevity and Anti-Aging Drugs Revenue 2017-2022 ($ Millions)
Figure 30. APAC Longevity and Anti-Aging Drugs Sales 2017-2022 (K Units)
Figure 31. APAC Longevity and Anti-Aging Drugs Revenue 2017-2022 ($ Millions)
Figure 32. Europe Longevity and Anti-Aging Drugs Sales 2017-2022 (K Units)
Figure 33. Europe Longevity and Anti-Aging Drugs Revenue 2017-2022 ($ Millions)
Figure 34. Middle East & Africa Longevity and Anti-Aging Drugs Sales 2017-2022 (K Units)
Figure 35. Middle East & Africa Longevity and Anti-Aging Drugs Revenue 2017-2022 ($ Millions)
Figure 36. Americas Longevity and Anti-Aging Drugs Sales Market Share by Country in 2021
Figure 37. Americas Longevity and Anti-Aging Drugs Revenue Market Share by Country in 2021
Figure 38. United States Longevity and Anti-Aging Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 39. Canada Longevity and Anti-Aging Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 40. Mexico Longevity and Anti-Aging Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 41. Brazil Longevity and Anti-Aging Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 42. APAC Longevity and Anti-Aging Drugs Sales Market Share by Region in 2021
Figure 43. APAC Longevity and Anti-Aging Drugs Revenue Market Share by Regions in 2021
Figure 44. China Longevity and Anti-Aging Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 45. Japan Longevity and Anti-Aging Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 46. South Korea Longevity and Anti-Aging Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 47. Southeast Asia Longevity and Anti-Aging Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 48. India Longevity and Anti-Aging Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 49. Australia Longevity and Anti-Aging Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 50. Europe Longevity and Anti-Aging Drugs Sales Market Share by Country in 2021
Figure 51. Europe Longevity and Anti-Aging Drugs Revenue Market Share by Country in 2021
Figure 52. Germany Longevity and Anti-Aging Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 53. France Longevity and Anti-Aging Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 54. UK Longevity and Anti-Aging Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 55. Italy Longevity and Anti-Aging Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 56. Russia Longevity and Anti-Aging Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 57. Middle East & Africa Longevity and Anti-Aging Drugs Sales Market Share by Country in 2021
Figure 58. Middle East & Africa Longevity and Anti-Aging Drugs Revenue Market Share by Country in 2021
Figure 59. Egypt Longevity and Anti-Aging Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 60. South Africa Longevity and Anti-Aging Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 61. Israel Longevity and Anti-Aging Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 62. Turkey Longevity and Anti-Aging Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 63. GCC Country Longevity and Anti-Aging Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 64. Manufacturing Cost Structure Analysis of Longevity and Anti-Aging Drugs in 2021
Figure 65. Manufacturing Process Analysis of Longevity and Anti-Aging Drugs
Figure 66. Industry Chain Structure of Longevity and Anti-Aging Drugs
Figure 67. Channels of Distribution
Figure 68. Distributors Profiles
